News and Insights of 3D Printing and Manufacturing
Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future.
Swedish bioprinting company Fluicell launched its second single-cell 3D bioprinter: the new Biopixlar AER is a compact 3D bioprinter that lets users create detailed biological tissues with high precision. It is the world’s first microfluidic high-precision bioprinter that fits inside a standard flow hood or biosafety cabinet. Fluicell designed it for high automation and easy workflow integration, with the goal of bringing Biopixlar technology to new customer segments.
Remember when, in 2017, scientists 3D printed an artificial ovary and implanted it into a sterile mouse, which later gave birth to healthy pups? Now, science has gone one step further by 3D printing testicular cells – showing promising early signs of sperm-producing capabilities.
Finland-based bioprinting firm Brinter, together with extrusion technology developer Puredyne, has announced the launch of its new Visco Bio printhead for use with its 3D bioprinters.
Nanoscribe and CELLINK, two BICO companies, today jointly unveiled the Quantum X bio, a revolutionary system as part of the Nanoscribe Quantum X platform providing researchers with a very accurate 3D bioprinter. The Quantum X bio is the first-of-its-kind bioprinter enabling submicron printing resolution. Powered by Two-Photon Polymerization (2PP), the Quantum X bio is the premier tool for miniaturizing bioprinting to redefine the development of complex tissue or cell scaffolds and of advanced biomedical applications.
Bioprinter manufacturer REGEMAT3D is launching a new equity crowdfunding round, that will help the company further scale its business and product lines while preparing for an IPO set to take place in 2023. At 3dpbm we usually do not cover crowdfunding campaigns for new products, however, this initiative is relative to a company that is already present in the market and has been making significant progress in the bioprinting segment. REGEMAT3D promises massive returns (up to 3 to 4 times the investment) and while the actual success of this financial initiative is subject to the same risks as any financial venture, the overall bioprinting segment is in fact growing up rapidly.
Bioprinting startup Brinter has today announced a partnership with LED Tailor to introduce the new Spectral Blue disinfecting blue light feature embedded in its multi-material 3D bioprinting solution Brinter. The system enables the safe production of e.g. tissue models and drugs, and minimizes the need for separate cleanrooms, making bioprinters more portable and safe.
3D bioprinting firm BICO has announced an initial $1.5 million contract manufacturing deal with regenerative joint replacement start-up Nanochon.
Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform.
The NOVOPLASM consortium has announced it is the “first in the world” to develop cold plasma technology for the treatment of infected burns and the wound healing of skin grafts.